Viewing Study NCT06431893


Ignite Creation Date: 2025-12-25 @ 1:23 AM
Ignite Modification Date: 2026-01-19 @ 2:04 PM
Study NCT ID: NCT06431893
Status: ENROLLING_BY_INVITATION
Last Update Posted: 2025-04-11
First Post: 2024-05-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 3 Long-term Extension Study to Assess the Long-term Safety and Efficacy of Pegtibatinase Treatment in Participants ≥5 to ≤65 Years of Age With Classical Homocystinuria (HCU) (ENSEMBLE)
Sponsor: Travere Therapeutics, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module